Japan

Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business
Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business
Yahoo/Reuters
Fujifilm
Biogen
M&A
Japan
biologics
Flag link:
Bayer files prostate cancer drug darolutamide in Japan
Bayer files prostate cancer drug darolutamide in Japan
Pharmaforum
Bayer
prostate cancer
darolutamide
Japan
JNJ
Pfizer
Astellas
Flag link:
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
BioSpace
Xofluza
Japan
Genentech
Flag link:
PhRMA urges USTR to address Japan's 'damaging' pricing policy, commends China's progress
PhRMA urges USTR to address Japan's 'damaging' pricing policy, commends China's progress
BioCentury
PhRMA
Japan
China
Flag link:
Takeda to keep consumer business, looks outside Japan for selloffs instead: CEO
Takeda to keep consumer business, looks outside Japan for selloffs instead: CEO
Fierce Pharma
Takeda
Japan
consumer health
Christophe Weber
Flag link:
Sun Pharma acquires two manufacturing plants in deal for Japanese company
Sun Pharma acquires two manufacturing plants in deal for Japanese company
Biopharma Dive
Sun Pharma
Japan
Pola Pharma
drug manufacturing
Flag link:
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Endpoints
Takeda
shareholders
Japan
M&A
Shire
Europe
Flag link:
J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
CNBC
JNJ
M&A
Japan
Flag link:
Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis
Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis
CP Wire
Alnylam
Patisiran
Onpattro
Japan
hATTR amyloidosis
Flag link:
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
CP Wire
Exelixis
Cabometyx
Takeda
Canada
Japan
Ipsen
renal cell carcinoma
Flag link:
AstraZeneca gets further approval for Tagrisso in Japan
AstraZeneca gets further approval for Tagrisso in Japan
Pharmaforum
AstraZeneca
Japan
Tagrisso
non-small cell lung cancer
Flag link:
Shire, Shionogi File NDA for Intuniv for Adults in Japan
Shire, Shionogi File NDA for Intuniv for Adults in Japan
Yahoo/Zacks.com
Shire
Shionogi
ADHD
Japan
Intuniv
Flag link:
Pharma reps get more respect from doctors in Japan. What's the takeaway for U.S. reps?
Pharma reps get more respect from doctors in Japan. What's the takeaway for U.S. reps?
Fierce Pharma
drug reps
Japan
Flag link:
Pharma reps and websites carry clout with physicians in Japan
Pharma reps and websites carry clout with physicians in Japan
Decision Resources Group
Japan
pharma reps
Decision Resources Group
Flag link:
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
CP Wire
AB928
Arcus Biosciences
Taiho Pharmaceutical
oncology
Asia
Japan
Flag link:
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Endpoints
Takeda
Shire
M&A
Japan
Flag link:
AstraZeneca wins speedy approvals for cancer drugs in Japan
AstraZeneca wins speedy approvals for cancer drugs in Japan
Yahoo/Reuters
AstraZeneca
Japan
Imfinzi
Lynparza
Flag link:
What to Expect for AstraZeneca in Fiscal 2018
What to Expect for AstraZeneca in Fiscal 2018
Market Realist
AstraZeneca
guidance
generics
Crestor
Japan
Europe
Flag link:
Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug
Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug
Fierce Biotech
Astellas
Aquinox Pharmaceuticals
SHIP1 activator
Japan
Asia
rosiptor
Flag link:
Myriad’s breast cancer diagnostic wins approval in Japan
Myriad’s breast cancer diagnostic wins approval in Japan
Drug Delivery Business News
Myriad Genetics
diagnostics
breast cancer
Japan
Bracanalysis Diagnostic System
Lynparza
Flag link:

Pages